Mulmit

Can-Fite BioPharma Ltd.Can-Fite BioPharma Ltd.

CANF NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31405,000-9,950,000-9,828,000-5.97
2024-12-31674,000-8,130,000-7,880,000-10.86
2023-12-31743,000-8,195,000-7,634,000-17.92
2022-12-31810,000-10,096,000-10,173,000-0.01
2021-12-31853,000-12,842,000-12,615,000-0.03

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-04Farbstein MottiCEO, CFO and COO24,000
2026-06-04Fishman PninaChief Scientific Officer24,000
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.